$ASMB· SEC filing ·

ASMB Licenses HPI Program to Gilead, $35M Option Fee, Phase 2 ABI-6250 2026

Assembly Biosciences, Inc · PHARMACEUTICAL PREPARATIONS · Now $26.92

Post-detection moves

1h
1d
3d
7d
30d

Get alerts like this in real time

Push notifications the moment a signal fires. No spam, no crypto, no fluff.

Download for iOS